In contrast to chondrosarcomas, osteosarcomas exhibit a higher degree of genomic instability, marked by frequent chromosomal rearrangements and elevated mutation rates in key cell cycle regulatory genes, such as TP53, PTEN, and CDKN2A/B. The gene discussed is TP53; the disease is chondrosarcoma.